DexCom Inc. Stock Underperforms Friday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.DexCom Inc. (DXCM) shares fell 1.71% to $76.65 on Friday, underperforming the broader market and competitors like Abbott Laboratories. The stock closed 14.81% below its 52-week high of $89.98. Trading volume was lower than the 50-day average. This performance occurred during a general market decline where the S&P 500 and Dow Jones also dropped.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of DexCom Inc. (DXCM) shed 1.71% to $76.65 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.01% to 7,457.69 and Dow Jones Industrial Average falling 0.77% to 52,146.42.
DexCom Inc. closed 14.81% below its 52-week high of $89.98, which the company achieved on July 30th.
The stock underperformed when compared to some of its competitors Friday, as Abbott Laboratories (ABT) rose 1.87% to $100.68 and Insulet Corp. (PODD) fell 0.23% to $164.06.
Trading volume (5.0 M) remained 897,756 below its 50-day average volume of 5.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-17-26 1658ET